vivoPharm, in addition to its role as a one stop shop for preclinical research needs, is actively engaged in developing novel technologies to allow us to better serve the pharmaceutical and biotechnology industry. vivoPharm has been focusing on development of a number of exciting new imaging technologies. These include in vivo imaging using bioluminescence and fluorescently labeled tumour cells. In addition to assessment of compounds™ efficacy, these technologies will allow for quantitative evaluation of compound mechanism of action. vivoPharm looks forward to working with our clients to further develop these and other imaging technologies to better serve client needs.